EcoDrugPlus

40s Ribosomal Protein S14

Ensembl ID : ENSAOCG00000015320
Gene Symbol: LOC111571098
3 Cross references
329 Possible Orthologues:

40s Ribosomal Protein S19

Ensembl ID : ENSAOCG00000020811
Gene Symbol: LOC111563382
3 Cross references
321 Possible Orthologues:

40s Ribosomal Protein S5

Ensembl ID : ENSAOCG00000010721
Gene Symbol: LOC111583594
4 Cross references
246 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSAOCG00000014242
Gene Symbol: NT5E
3 Cross references
190 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSAOCG00000018583
Gene Symbol: NT5E
4 Cross references
194 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1a B

Ensembl ID : ENSAOCG00000016488
Gene Symbol: HTR1AB
1 Cross references
138 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2c, G Protein-Coupled-Like 1

Ensembl ID : ENSAOCG00000016005
Gene Symbol: HTR2CL1
1 Cross references
201 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSAOCG00000014169
Gene Symbol: HTR1B
2 Cross references
178 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSAOCG00000018599
Gene Symbol: HTR1B
3 Cross references
180 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSAOCG00000023530
Gene Symbol: HTR1E
4 Cross references
147 Possible Orthologues:

5-Hydroxytryptamine Receptor 1f

Ensembl ID : ENSAOCG00000011402
Gene Symbol: HTR1F
4 Cross references
140 Possible Orthologues:

5-Hydroxytryptamine Receptor 2a

Ensembl ID : ENSAOCG00000021218
Gene Symbol: HTR2A
1 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).